27 March 2021>: Clinical Research
Use of the Water-Soluble Contrast Medium Gastrografin in Treatment of Adhesive Small Bowel Obstruction in Patients with and Without Chronic Radiation Enteropathy: A Single-Center Retrospective Study
Lili Gu 1BCEF , Feng Zhu 1BDE , Tingbin Xie 1BCD , Dengyu Feng 1BEF , Jianfeng Gong 1BDEG* , Ning Li 2ABEFG*DOI: 10.12659/MSM.930046
Med Sci Monit 2021; 27:e930046
Table 1 Patient characteristics of CRE-induced SBO and ASBO.
CRE induced SBO (n=59) | Adhesive SBO (n=53) | p Value | |
---|---|---|---|
Sex ratio (M: F) | 19: 40 | 16: 37 | |
Mean age (years) | 55.6 | 52.5 | 0.77 |
Blood tests | |||
Albumin (g/l) | 39.49±6.27 | 38.69±5.2 | 0.68 |
White blood cells (/mm) | 4.96±2.74 | 5.19±2.95 | 0.60 |
Platelet (10/L) | 211.62±62.42 | 208.52±64.11 | 0.75 |
C-reactive protein (mg/l) | 13.53±30.42 | 18.18±32.13 | 0.29 |
Body mass index (BMI) (Kg/m) | 18.8±3.53 | 18.6±3.13 | 0.25 |
Abdominal CT-scan | |||
Junction sign | 31 (52.5) | 24 (45.2) | 0.46 |
Peritoneal effusion | 14 (23.7) | 18 (33.9) | 0.15 |
Abnormal small bowel wall vascularization | 18 (50.9) | 9 (16.9) | 0.22 |
Mesenteric infiltration | 7 (11.8) | 12 (22.6) | 0.18 |
Type of previous abdominal surgery | |||
Appendectomy | 10 (16.9) | 9 (16.9) | 0.89 |
Gastroduodenal | 6 (10.2) | 4 (7.5) | 0.51 |
Small bowel | 3 (5.1) | 5 (9.4) | 0.40 |
Colorectal | 20 (33.9) | 20 (37.7) | 0.85 |
Trauma exploration | |||
Cholecystectomy | 4 (6.8) | 3 (5.6) | 0.78 |
Gynecologic surgery | 7 (11.9) | 3 (5.6) | 0.70 |
Adhesolysis | 8 (13.5) | 20 (37.7) | |
Duration of symptoms before admission (hours) | 27.8±6.8 | 29.5±7.7 | 0.94 |